BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34583688)

  • 1. Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
    Zhang A; Zhong G; Wang L; Cai R; Han R; Xu C; Chen S; Sun P; Chen H
    Cancer Cell Int; 2021 Sep; 21(1):518. PubMed ID: 34583688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
    Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
    Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a nomogram to predicting the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma.
    Chen Y; Chen D; Wang R; Xie S; Wang X; Huang H
    Clin Transl Oncol; 2024 May; ():. PubMed ID: 38710900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.
    Chen X; Liang W; Wu X; Wang Y; Hong Y; Xie M; Han R; Lin Z
    Medicine (Baltimore); 2024 May; 103(19):e38017. PubMed ID: 38728499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.
    Wu YX; Tian BY; Ou XY; Wu M; Huang Q; Han RK; He X; Chen SL
    Cancer Immunol Immunother; 2024 Jan; 73(1):14. PubMed ID: 38236288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 7. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling.
    Zhou J; Deng Y; Huang Y; Wang Z; Zhan Z; Cao X; Cai Z; Deng Y; Zhang L; Huang H; Li C; Lv X
    Life (Basel); 2023 May; 13(5):. PubMed ID: 37240811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma.
    Xue N; Ou G; Ma W; Jia L; Sheng J; Xu Q; Liu Y; Jia M
    Cancer Cell Int; 2021 Aug; 21(1):452. PubMed ID: 34446028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and evaluation of an artificial intelligence-based risk prediction model for death in patients with nasopharyngeal cancer].
    Zhang H; Lu J; Jiang C; Fang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):271-279. PubMed ID: 36946048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma.
    Shen H; Wang Y; Liu D; Lv R; Huang Y; Peng C; Jiang S; Wang Y; He Y; Lan X; Huang H; Sun J; Zhang J
    Front Oncol; 2020; 10():618. PubMed ID: 32477932
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.
    Xiong Y; Shi LL; Zhu LS; Peng G
    Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
    Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
    EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
    Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
    Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
    Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
    BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
    Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
    J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy.
    Lv SH; Li WZ; Liang H; Liu GY; Xia WX; Xiang YQ
    J Inflamm Res; 2021; 14():2225-2237. PubMed ID: 34079329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.